Effects of chronic nicotine on food intake and anxiety-like behaviour in CB1 knockout mice

European Neuropsychopharmacology

Volumn 20, Issue 6, 2010, Pages 369-378

  Bura, S Andreea ^a   Burokas, Aurelijus ^a   Martín García, Elena ^a   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Anxiety; CB1 receptor; Drink intake; Food intake; Nicotine

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; SACCHARIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; FOOD PREFERENCE; KNOCKOUT MOUSE; LIPID DIET; LOCOMOTION; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOBACCO DEPENDENCE; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIETARY FATS; DRINKING; EATING; ENERGY INTAKE; FOOD PREFERENCES; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; RECEPTOR, CANNABINOID, CB1; SACCHARIN;

EID: 77952549805     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.02.003     Document Type: Article

References (49)

1. Andersson K., Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1225-1232.
2. Aso E., Renoir T., Mengod G., Ledent C., Hamon M., Maldonado R., Lanfumey L., Valverde O. Lack of CB1 receptor activity impairs serotonergic negative feedback. J. Neurochem. 2009, 109:935-944.
3. Balerio G.N., Aso E., Berrendero F., Murtra P., Maldonado R. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur. J. NeuroSci. 2004, 20:2737-2748.
4. Balerio G.N., Aso E., Maldonado R. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 2006, 184:504-513.
5. Barbano M.F., Castane A., Martin-Garcia E., Maldonado R. Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test. Psychopharmacology (Berl) 2009, 205:475-487.
6. Bellocchio L., Cervino C., Pasquali R., Pagotto U. The endocannabinoid system and energy metabolism. J. Neuroendocrinol. 2008, 20:850-857.
7. Belzung C., Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav. 1994, 56:623-628.
8. Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le F.G., Oury-Donat F., Soubrie P. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol. Pharmacol. 2003, 63:908-914.
9. Bernaards C.M., Twisk J.W., Snel J., van M.W., Kemper H.C. In a prospective study in young people, associations between changes in smoking behavior and risk factors for cardiovascular disease were complex. J. Clin. Epidemiol. 2005, 58:1165-1171.
10. Berrendero F., Mendizabal V., Robledo P., Galeote L., Bilkei-Gorzo A., Zimmer A., Maldonado R. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 2005, 25:1103-1112.
11. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert. Rev. Cardiovasc. Ther. 2008, 6:883-895.
12. Burdyga G., Lal S., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci. 2004, 24:2708-2715.
13. Castañé A., Berrendero F., Maldonado R. The role of the cannabinoid system in nicotine addiction. Pharmacol. Biochem. Behav. 2005, 81:381-386.
14. Castañé A., Valjent E., Ledent C., Parmentier M., Maldonado R., Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 2002, 43:857-867.
15. Chen H., Hansen M.J., Jones J.E., Vlahos R., Bozinovski S., Anderson G.P., Morris M.J. Regulation of hypothalamic NPY by diet and smoking. Peptides 2007, 28:384-389.
16. Cohen C., Kodas E., Griebel G. CB1 receptor antagonists for the treatment of nicotine addiction. Pharmacol. Biochem. Behav. 2005, 81:387-395.
17. Cook J.W., Spring B., McChargue D. Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl) 2007, 192:87-95.
18. Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 2008, 20(Suppl 1):35-38.
19. Damaj M.I., Kao W., Martin B.R. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J. Pharmacol. Exp. Ther. 2003, 307:526-534.
20. Di Marzo V., Bifulco M., De P.L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 2004, 3:771-784.
21. Di Marzo V., Matias I. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 2005, 8:585-589.
22. Forget B., Hamon M., Thiebot M.H. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 2005, 181:722-734.
23. Gomez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del A.I., Cippitelli A., Nava F., Piomelli D., Rodriguez de F.F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 2002, 22:9612-9617.
24. Hughes J.R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob. Res. 2007, 9:315-327.
25. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends Neurosci. 1999, 22:62-67.
26. Kirkham T.C. Endocannabinoids in the regulation of appetite and body weight. Behav. Pharmacol. 2005, 16:297-313.
27. Lamota L., Bermudez-Silva F.J., Marco E.M., Llorente R., Gallego A., Rodriguez de F.F., Viveros M.P. Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats. Neuropharmacology 2008, 54:194-205.
28. Liu R.H., Mizuta M., Matsukura S. Long-term oral nicotine administration reduces insulin resistance in obese rats. Eur. J. Pharmacol. 2003, 458:227-234.
29. Liu Y.L., Connoley I.P., Wilson C.A., Stock M.J. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int. J. Obes. (Lond) 2005, 29:183-187.
30. Mabley J.G., Pacher P., Southan G.J., Salzman A.L., Szabo C. Nicotine reduces the incidence of type I diabetes in mice. J. Pharmacol. Exp. Ther. 2002, 300:876-881.
31. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006, 29:225-232.
32. Mano-Otagiri A., Iwasaki-Sekino A., Ohata H., Arai K., Shibasaki T. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor. Neurosci. Lett. 2009, 455:26-29.
33. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002, 159:379-387.
34. Matias I., Gonthier M.P., Orlando P., Martiadis V., De P.L., Cervino C., Petrosino S., Hoareau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., Di M.V. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 2006, 91:3171-3180.
35. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Batkai S., Harvey-White J., Mackie K., Offertaler L., Wang L., Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest 2005, 115:1298-1305.
36. Perkins K.A. Effects of tobacco smoking on caloric intake. Br. J. Addict. 1992, 87:193-205.
37. Poirier B., Bidouard J.P., Cadrouvele C., Marniquet X., Staels B., O'Connor S.E., Janiak P., Herbert J.M. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes. Metab. 2005, 7:65-72.
38. Pomerleau O.F., Pomerleau C.S. Behavioural studies in humans: anxiety, stress and smoking. Ciba Found. Symp. 1990, 152:225-235.
39. Ravinet T.C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., Soubrie P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R345-R353.
40. Ravinet T.C., Delgorge C., Menet C., Arnone M., Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 2004, 28:640-648.
41. Rodriguez de F.F., Fernandez-Ruiz J.J., Murphy L., Eldridge J.C., Steger R.W., Bartke A. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol. Biochem. Behav. 1991, 40:593-598.
42. Spring B., Cook J.W., Appelhans B., Maloney A., Richmond M., Vaughn J., Vanderveen J., Hedeker D. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl) 2008, 196:461-471.
43. Thornton-Jones Z.D., Vickers S.P., Clifton P.G. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology (Berl) 2005, 179:452-460.
44. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark E., Janowsky D.S., Kling M.A. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) 1999, 142:193-199.
45. Viveros M.P., Marco E.M., File S.E. Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci. Biobehav. Rev. 2006, 30:1161-1181.
46. Ward S.J., Dykstra L.A. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav. Pharmacol. 2005, 16:381-388.
47. Weidenfeld J., Bodoff M., Saphier D., Brenner T. Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 1989, 50:132-138.
48. Winders S.E., Grunberg N.E. Effects of nicotine on body weight, food consumption and body composition in male rats. Life Sci. 1990, 46:1523-1530.
49. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A 1999, 96:5780-5785.